Whether a minimal circulating-protein signature anticipates incident cancer in patients with atheromatous cardiovascular disease exposed to tobacco is asked and estimates are conditional on the cancer frequency of this population, conditional on the cancer frequency of this population.
This study investigated potential plasma biomarkers associated with cancer risk and mortality in patients with type 2 diabetes mellitus (T2DM), a population known to have an increased cancer incidence and poorer outcomes compared with non-diabetic individuals. Traditional metabolic indicators, including blood pressure,...
PIS provides a compact, interpretable proteomic measure of inflammaging and captures mortality, multisystem disease burden, and aging-related biology in population-scale cohorts.
Prospective plasma proteomic analyses identified circulating proteins associated with future PCa risk, including proteins related to immune, adhesion, angiogenesis, and PCa driver-gene pathways.
Zhe Huang, M. Parsaeian, V. Viallon et al.· European Urology· 0 citations
Abstract The causes of most cancers remain unknown because the biological pathways underlying cancer development are poorly understood. Large-scale plasma proteomics offers a powerful strategy to uncover these pathways, identify biomarkers for cancer early detection, and discover novel therapeutic targets but has rarel...
J. Yarmolinsky, V. Viallon, V. Burk et al.· medRxiv· 0 citations
Findings support ProAL50 as a biologically informative, protein-based surrogate of AL for research use that complements traditional AL, pending further external validation and assay standardization.
Yu-Fan Guan, Jie Shen, Li Li et al.· Proteomes· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.